NCT04606771: A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC
- State
- Under way
- Phase
- Phase 2
- People
- 30 taking part
- Started
- 28 Sep 2020
- Primary completion
- 21 Dec 2022
- Arms
- Arm A
- Results
- Posted on the registry
- 28 Sep 2020: Trial started
- 28 Oct 2020: Trial registered
- 24 Sep 2024: Trial results posted